Australia's MedAdvisor falls on lower qtrly revenue
** Shares of MedAdvisor MDR.AX down 5% at A$0.19
** Stock hit lowest level since Dec. 27
** Medical software co says Q2 FY25 operating revenue fell
by 38.6% to A$30.8 million ($19.20 million)
** However, co expects stronger second half through
diversified U.S. pipeline for various health program, others
** Stock down 11.1% this year, as of last close
($1 = 1.6044 Australian dollars)
(Reporting by Sherin Sunny in Bengaluru)
((Sherin.Sunny@thomsonreuters.com))
Recent news on Adheris Health
See all newsBrief: Adheris Health Posts Q3 Operating Revenue Of A$5.4M
Brief: Adheris Health Posts HY Profit From Ordinary Activities After Tax Attributable A$7.3 Million
Brief: Adheris Health Expects 30% Total Operating Cost Savings Over Two Years
Brief: Adheris Health Posts Q2 Operating Revenue A$13.7 Million
Brief: Adheris Health Says A$6.1M Holdback Consideration Received